GoAI
Get started
Tsumura & Co. logo

Tsumura & Co.

4540.T

JPXHealthcareDrug Manufacturers - Specialty & Generic

Open in GoAI

Latest quote

¥3,771

+¥4.00 · +0.11%

Aug 24, 3:30 PM JST

4540.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Established in Tokyo, Japan, in 1893, Tsumura & Co. operates worldwide in the pharmaceutical sector. The company's core business involves the creation and international distribution of various medicinal products, with a particular focus on Kampo extract intermediates and granular Kampo preparations. Its operations are comprehensive, encompassing the full supply chain: from the careful acquisition, selection, processing, and warehousing of raw herbal materials and crude drug components for decoctions, to the manufacturing of powdered Kampo extracts and traditional Chinese medicines. Additionally, Tsumura & Co. is engaged in the sale of both pharmaceutical goods and food products.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Headquarters
JP
CEO
Terukazu Kato
Listed since
Jan 1, 2001
Employees
4,923

Market position

52-week range

Current ¥3,771

Open
¥3,771
Previous close
¥3,767
Volume
0
0× average
Average volume
338.28K
Average daily volume
Market cap
281.11B JPY
Beta
0.07
Market reference 1
50-day average
¥3,784.66
-0.36% below average
200-day average
¥3,870.88
-2.58% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
331B JPY
EV / EBITDA
6×
Earnings yield
10.04%
Free cash flow yield
-2.88%

Profitability & efficiency

Return on equity
8.74%
Return on assets
4.74%
Return on invested capital
4.97%

Financial health

Current ratio
4.19×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends55%39%23%7%Gross margin, FY2022: 51.31%Gross margin, FY2023: 48.76%Gross margin, FY2024: 45.62%Gross margin, FY2025: 50.02%Gross margin, FY2026: 47.51%Operating margin, FY2022: 17.27%Operating margin, FY2023: 14.94%Operating margin, FY2024: 13.27%Operating margin, FY2025: 22.16%Operating margin, FY2026: 18.29%Net margin, FY2022: 14.54%Net margin, FY2023: 11.77%Net margin, FY2024: 11.08%Net margin, FY2025: 17.91%Net margin, FY2026: 14.60%FY2022FY2023FY2024FY2025FY2026
Gross margin FY2022 51.31%. Gross margin FY2023 48.76%. Gross margin FY2024 45.62%. Gross margin FY2025 50.02%. Gross margin FY2026 47.51%. Operating margin FY2022 17.27%. Operating margin FY2023 14.94%. Operating margin FY2024 13.27%. Operating margin FY2025 22.16%. Operating margin FY2026 18.29%. Net margin FY2022 14.54%. Net margin FY2023 11.77%. Net margin FY2024 11.08%. Net margin FY2025 17.91%. Net margin FY2026 14.60%.

Income trends

Revenue

192.62B JPY+6.36%

Operating income

35.22B JPY-12.22%

Net income

28.12B JPY-13.29%
Income trends across reported periods210.23B JPY139.78B JPY69.32B JPY−1.13B JPYRevenue, FY2022: 129.55B JPYRevenue, FY2023: 140.04B JPYRevenue, FY2024: 150.85B JPYRevenue, FY2025: 181.09B JPYRevenue, FY2026: 192.62B JPYOperating income, FY2022: 22.38B JPYOperating income, FY2023: 20.92B JPYOperating income, FY2024: 20.02B JPYOperating income, FY2025: 40.13B JPYOperating income, FY2026: 35.22B JPYNet income, FY2022: 18.84B JPYNet income, FY2023: 16.48B JPYNet income, FY2024: 16.71B JPYNet income, FY2025: 32.43B JPYNet income, FY2026: 28.12B JPYFY2022FY2023FY2024FY2025FY2026
Revenue FY2022 129.55B JPY. Revenue FY2023 140.04B JPY. Revenue FY2024 150.85B JPY. Revenue FY2025 181.09B JPY. Revenue FY2026 192.62B JPY. Operating income FY2022 22.38B JPY. Operating income FY2023 20.92B JPY. Operating income FY2024 20.02B JPY. Operating income FY2025 40.13B JPY. Operating income FY2026 35.22B JPY. Net income FY2022 18.84B JPY. Net income FY2023 16.48B JPY. Net income FY2024 16.71B JPY. Net income FY2025 32.43B JPY. Net income FY2026 28.12B JPY.
Metric (JPY)FY2026FY2025FY2024FY2023FY2022
Revenue192.62B JPY181.09B JPY150.85B JPY140.04B JPY129.55B JPY
Cost of goods sold101.1B JPY90.51B JPY82.03B JPY71.76B JPY63.08B JPY
Gross profit91.52B JPY90.58B JPY68.82B JPY68.28B JPY66.47B JPY
Research and development—8.36B JPY8.29B JPY7.59B JPY7.31B JPY
Selling, general, and administrative56.3B JPY42.1B JPY40.51B JPY39.77B JPY36.78B JPY
Operating expenses56.3B JPY50.46B JPY48.8B JPY47.37B JPY44.09B JPY
Interest income573M JPY628M JPY671M JPY531M JPY443M JPY
Interest expense1.05B JPY518M JPY330M JPY398M JPY173M JPY
Depreciation and amortization13.06B JPY11.17B JPY10.75B JPY10.61B JPY9.19B JPY
Operating income35.22B JPY40.13B JPY20.02B JPY20.92B JPY22.38B JPY
Net income28.12B JPY32.43B JPY16.71B JPY16.48B JPY18.84B JPY

Company facts updated Aug 24, 2026.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥136

2025 complete year+112.5% since 2021

2026 partial: ¥79.00

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Sep 29, 2026

¥79.00

Semi-Annual

Record Sep 30, 2026 · Payment Sep 29, 2026

DividendUpcoming

Ex-dividend Mar 30, 2027

¥79.00

Semi-Annual

Record Mar 31, 2027 · Payment Mar 30, 2027

Dividend

Ex-dividend Mar 30, 2026

¥79.00

Semi-Annual

Record Mar 31, 2026 · Payment Jun 29, 2026

Dividend

Ex-dividend Sep 29, 2025

¥68.00

Semi-Annual

Record Sep 30, 2025 · Payment Dec 5, 2025

Dividend

Ex-dividend Mar 28, 2025

¥68.00

Semi-Annual

Record Mar 31, 2025 · Payment Jun 30, 2025

Dividend

Ex-dividend Sep 27, 2024

¥68.00

Semi-Annual

Record Sep 30, 2024 · Payment Dec 5, 2024

4540.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,987

-0.34%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,797

+0.57%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,895

0.00%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,210

+0.12%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,858

+0.86%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,406.5

+0.82%

ETFs holding 4540.T

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Core TOPIX ETF logoiShares Core TOPIX ETF1475.T
Market value
664.88M
Weight
0.02%
AUM
2.89T JPY
Expense ratio
0.05%
Price / 1D
¥417.7-0.07%
Vanguard Total International Stock ETF logoVanguard Total International Stock ETFVXUS
Market value
23.1M
Weight
0.00%
AUM
646.2B USD
Expense ratio
0.05%
Price / 1D
$87.20-0.58%
Vanguard FTSE Developed Markets ETF logoVanguard FTSE Developed Markets ETFVEA
Market value
15.58M
Weight
0.00%
AUM
315B USD
Expense ratio
0.03%
Price / 1D
$73.06-0.49%
iShares Core MSCI EAFE ETF logoiShares Core MSCI EAFE ETFIEFA
Market value
10.77M
Weight
0.01%
AUM
195.14B USD
Expense ratio
0.07%
Price / 1D
$100.67-0.18%
Dimensional - International Small Cap Value ETF logoDimensional - International Small Cap Value ETFDISV
Market value
6.29M
Weight
0.12%
AUM
5.23B USD
Expense ratio
0.42%
Price / 1D
$44.48-0.02%
iShares MSCI EAFE Small-Cap ETF logoiShares MSCI EAFE Small-Cap ETFSCZ
Market value
4.83M
Weight
0.04%
AUM
13.28B USD
Expense ratio
0.40%
Price / 1D
$86.50-0.12%
Vanguard FTSE All-World ex-US ETF logoVanguard FTSE All-World ex-US ETFVEU
Market value
3.62M
Weight
0.00%
AUM
95.9B USD
Expense ratio
0.04%
Price / 1D
$85.21-0.56%
Dimensional - International Small Cap ETF logoDimensional - International Small Cap ETFDFIS
Market value
3.61M
Weight
0.06%
AUM
5.91B USD
Expense ratio
0.39%
Price / 1D
$37.45-0.25%

Continue in GoAI

Research 4540.T

research.disclaimer